- Elez, E., Ros, J., Fernández, J., Villacampa, G., Moreno-Cardenas, A. B., Arenillas, C., . . . Tabernero, J., Toledo, R. A. RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF(V600E) metastatic colorectal cancer. (2022). Nature Medicine, 28(10), 2162-2170. https://doi.org/10.1038/s41591-022-01976-z
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF(V600E) metastatic colorectal cancer
on 2 de novembre de 2022
with No hi ha comentaris
Deixa un comentari